Past Presidents Dinner, November 2022

Past Presidents Dinner, November 2022

Past Presidents Dinner, November 2022

Past Presidents of LUGPA

William B. Monnig, MD,
President 2009

William Monnig, MD of The Urology Group served as LUGPA’s first president from 2008-2009. He was one of the founding members of The Urology Group, and a visionary in establishing LUGPA as the nation’s only Urology trade association.

Dr. Monnig was a graduate of the University of Cincinnati College of Medicine in 1969 and received his surgical and urology training at the University of Cincinnati. He was very involved in organized urology and was a member of the American Urological Association and the American Association of Clinical Urologists. Dr. Monnig also served as President of the Kentucky Medical Association and in the AMA’s House of Delegates for many years.

Dr. Monnig passed away on March 27, 2022. LUGPA is indebted to his efforts and his legacy lives on in future generations of independent urologists. We are grateful for his leadership and wise counsel.  

Peter M. Knapp Jr., MD, FACS
President 2010 

Dr. Peter Knapp is Co-Founder and Past President of Urology of Indiana, Volunteer Clinical Associate Professor of Urology at the Indiana University School of Medicine and currently serves on the Board of Directors of US Urology Partners.

Dr. Knapp has also been active in urologic association development, leadership and advocacy. He was a founding board member and Past President of LUGPA. He is Past President of the North Central Section of the American Urologic Association, and served on the American Association of Clinical Urologists Board of Directors remaining active in health policy activities for urologists and their patients.

Dr. Knapp was Co-Founder and Director of Strand Diagnostics LLC, a molecular diagnostics laboratory in Indianapolis. In this role, he co-developed the patented Know Error DNA Specimen Provenance Assay (DSPA) used to improve diagnostic accuracy, eliminate medical errors due to specimen switches and contamination, and provide patient safety in the diagnosis of cancer. Dr. Knapp also holds patents in urologic stenting and tissue engineering and currently serves as a consultant to healthcare companies providing strategic guidance on product development, application and commercialization.

He is a graduate of Indiana University School of Medicine and completed his general surgery internship and urology residency at the University of Michigan. He is certified by the American Board of Urology with subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery and is a fellow of the American College of Surgeons. He has a special interest in the management of urinary incontinence, OAB, BPH, neurourology, uroprostheses, and pelvic reconstructive surgery. He has published and presented on these topics as well as quality control and outcomes initiatives in urology group practices.

.

Raoul S. Concepcion, MD, FACS
President 2011   

Raoul S. Concepcion is the Chief Science Officer of U.S. Urology Partners. Dr. Concepcion has decades of experience as a pioneer and clinician at the forefront of the urology industry, including serving as a founding member and former President of LUGPA, the premier nonprofit association and advocate for independent urology practices.

A native of central Ohio, Dr. Concepcion has been a Clinical Assistant Professor in the Department of Urology, Vanderbilt University School of Medicine. He was a General Surgery and Urology Resident from 1984 to 1989 and served as Chief Urology Resident from 1989 to 1990. Additionally, he was a research fellow in the Light Laboratories at Vanderbilt. More recently, he has completed The City of Hope Intensive Course on Cancer Risk Assessment for hereditary cancer and genomic testing. He has been in practice since 1990, with his major clinical interest being Urologic Oncology, specializing in advanced prostate and bladder cancer and lower urinary tract reconstruction, as well as the role of genomics and genetic testing in GU tumors. He is Board Certified by the American Urological Association (AUA) and is a member of that organization, as well as the Southeastern Section of the AUA, Society of Urologic Oncology, American College of Surgeons and the Nashville Surgical Society.

From a research perspective, Dr. Concepcion has been actively in involved in basic science and clinical research since his days at Vanderbilt. Dr. Concepcion has been either the principal investigator (PI) or Co-PI on many clinical trials since the 1990s. The focus as of recent has been in advanced prostate cancer, as well as biomarker development. He co-founded CUSP, a Urology-specific clinical trials management company that specialized in site and patient accrual for the pharmaceutical and biolab industries. From an industry perspective, Dr. Concepcion serves as an advisor, consultant or speaker for many companies involved in the diagnosis and management of prostate cancer. He is developing a precision medicine comprehensive prostate cancer program for U.S. Urology Partners and affiliated groups, centered on genomic testing, pathway development, data aggregation and clinical trial work.

Deepak A. Kapoor, MD 
President 2012-2013 

Dr. Kapoor is Chairman and Chief Ecosystem Officer of Solaris Health Holdings, LLC, Market President for Integrated Medical Professionals, PLLC (IMP) and President of Advanced Urology Centers of New York. His expertise includes basic science research in molecular biology, as well as extensive experience in oncologic and reconstructive surgery.

Dr. Kapoor is Clinical Professor of Urology at the Icahn School of Medicine at Mount Sinai, Chair of the LUGPA Health Policy Committee, and Chairman of SCRUBS RRG. He has also served as a Director of UroPAC and Chairman of Access to Integrated Cancer Care. Dr. Kapoor was the founder of the New York Urology Trade Association and Integrated Medical Foundation. In addition, he is a Fellow of the American College of Physician Executives.

Dr. Kapoor has published and lectured extensively on clinical, business and health policy issues and is Associate Editor of the journal Urology Practice. He serves on a number of medical advisory boards, including the New York State Governor´s Prostate Cancer Advisory Panel. Dr. Kapoor has received numerous accolades, including the 2011 AUA Ambrose-Reed socioeconomic essay award, the 2014 New York Section AUA Russell W. Lavengood distinguished service award and was recognized in 2018 by LUGPA for outstanding contributions to health policy and the preservation of independent medicine.

Juan A. Reyna, MD
President 2014

A practicing urologist, Dr. Reyna is the Founder and President Emeritus of Urology San Antonio, one of the largest urology groups in the United States and is now affiliated with the Audie L Murphy Memorial VA Hospital. 

Educated in the United States, Dr. Reyna earned his undergraduate degrees from San Antonio College and the University of Texas Pharmacy School. He then went on to graduate with his medical degree from the Joe R. and Teresa Lozano Long School of Medicine in 1975 and completed his surgical internship at Baylor College of Medicine in Houston. He returned to his hometown, San Antonio, for his residency in urology at the UT Health Science Center, where he was the first Mexican American to complete the program.

In 1981, Dr. Reyna opened his urology practice as a solo practitioner in downtown San Antonio. Through recruitment and mergers, he grew the practice to include 30 urologists, a radiation oncologist, and approximately 200 employees. He served as the group’s President and CEO for 30 years before stepping down in May of 2012. In recognition of Dr. Reyna’s 31 years of service, Urology San Antonio changed the name of their cancer center  to The Dr. Johnny Reyna Center for Cancer Treatment.

In 2014, Dr. Reyna served as president of LUGPA. He is a founding member of the Mexican American Hispanic Physician Association, an organization that empowers minority students to pursue careers in health care. He has also served on numerous boards for businesses, hospitals, and professional associations in San Antonio and at the national level.

Named a Texas Super Doctor from the years 2005 to 2011, his expertise in managed care and group consolidation has allowed him to give presentations on these topics all over the United States and in Mexico and Panama.

Gary M. Kirsh, MD 
President 2015-2016     

Dr. Gary Kirsh has served as the President of The Urology Group, headquartered in Cincinnati, Ohio, since 2009. The group operates integrated surgical, imaging, laboratory, radiation, pharmacy, and clinical research services and is the largest provider of urologic care in the Cincinnati metropolitan region of over two million lives.

In 2020, Dr. Kirsh was a co-founder of Solaris Health, where he serves as President and CEO. Since founding, Solaris has grown to become the largest provider of urologic services in the U.S.

Dr. Kirsh has a long history of involvement in urologic health policy and advocacy. He is a past Chairman of UROPAC, urology’s national political action committee, and a past-president of the American Association of Clinical Urologists, the North Central Section of the American Urological Association, and the Ohio Urologic Society.

In 2008, Dr. Kirsh was instrumental in founding LUGPA, a national trade association representing independent urologists. Dr. Kirsh has previously served as LUGPA’s Secretary, President and Chair of its Alternative Payment Model Task Force, and he continues as Chairman of LUGPA Political Affairs.

Dr. Kirsh has frequently spoken across the country on practice management, and the socioeconomic issues facing independent medicine. He has provided legislative testimony in support of physicians’ issues at both the state level and in the U.S. Congress.

Dr. Kirsh earned his medical degree from the University of Chicago, Pritzker School of Medicine in 1984. He completed his residency in urology at Case Western Reserve University in Cleveland, Ohio, in 1989.

Neal D. Shore, MD
President 2017-2018 

Dr. Neal Shore is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.

Dr. Shore has conducted more than 350 clinical trials focusing mainly on GU Oncology, and serves on the Executive Boards of the following: Society of Urologic Oncology, Bladder Cancer Advocacy Network, Society of Urologic Oncology Clinical Trials Consortium and is a past president of LUGPA. He is a founder of the CUSP Clinical Trials Consortium as well as DASHKO (large urology practices data registries). He serves as the National Urology Research Director for 21st Century Oncology. He has served on the AUA Male Health Committee and the AUA Data Committee, the SITC Task Force for Prostate Cancer, the Bladder Cancer Advocacy Think Tank, and the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, World Journal of Urology, and serves as Editor for Everyday Urology-Oncology. He has written more than 125 peer-reviewed publications and numerous book chapters. He performs peer review for Lancet Oncology, European Urology, Journal Urology, Urology, BJUI, PCPD, and numerous other high-impact scientific journals.

A graduate of Duke University and Duke University Medical School, Dr. Shore completed a six-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons. 

Richard G. Harris, MD  
President 2019-2020 

Dr. Harris has been a practicing urologist in Chicago for more than thirty years and he is a founding member and CEO of UroPartners, an integrated urology practice with more than 60 physicians. 

Richard G. Harris, MD, was elected to as president of LUGPA’s 2019 Board of Directors at the 10th Annual Meeting. Prior to his service as president, Dr. Harris served as president-elect and secretary and has been a member of the LUGPA Board of Directors since 2010.

Dr. Harris attended Washington University in St. Louis and the Chicago Medical School. He then completed his residency in general surgery and urology at Loyola University Medical Center in Chicago, and currently serves as the assistant clinical professor of urology. His main focus in urology is prostate cancer, specifically metastatic castrate resistant cancer.

Jonathan Henderson, MD
President 2021-2022

Dr. Henderson earned a Bachelor of Science Degree at LSU in Baton Rouge in microbiology. After receiving his M.D. at LSU Medical Center in Shreveport, he completed his internship and residency in Urology at LSUMC Hospital.

Dr. Henderson spent the next six years in practice in Alabama where he pioneered urologic laparoscopy. In 2002, Dr. Henderson was asked to return to Shreveport to join the nascent Regional Urology and served as CEO. In March 2022 Dr. Henderson joined Arkansas Urology in Little Rock, Arkansas.

Dr. Henderson is certified by the American Board of Urology. He is a member of the Alpha Omega Alpha Medical Honor Society and the American Urologic Association (and sits on many committees for that organization). He has been on the LUGPA Board of Directors since 2011.